Note
9 – Accounts Payable and Accrued Expenses
The
Company’s accounts payable and accrued expenses consist of the following for the periods presented:
Schedule
of Accounts Payable and Accrued Expenses
| |
June 30, 2025 | | |
December 31, 2024 | |
| |
(In thousands) | |
Accounts payable | |
$ | 38,313 | | |
$ | 19,285 | |
Accrued capital expenditures | |
| 15,692 | | |
| 14,136 | |
Accrued operating expenses (1) | |
| 11,135 | | |
| 435 | |
Accrued transaction and
financing costs (2) | |
| 7,440 | | |
| 423 | |
Incentive compensation | |
| 3,033 | | |
| 2,571 | |
Accrued interest | |
| 2,609 | | |
| 325 | |
Other | |
| 1,167 | | |
| 1,050 | |
Accounts payable and accrued expenses | |
$ | 79,389 | | |
$ | 38,225 | |
(1) |
Accrued
operating expenses as of June 30, 2025 are inclusive of Bayswater costs
incurred during the period since the closing of the Bayswater Acquisition on March 26, 2025. Refer to Note 3 – Acquisitions for
a discussion of the Bayswater Acquisition. |
(2) |
Accrued transaction and financing costs as of June 30, 2025 are comprised
of the remaining costs incurred to close and fund the Bayswater Acquisition during the first quarter. Refer to Note 3 – Acquisitions
for a discussion of the Bayswater Acquisition. |
|